| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 31.47▼ | 31.47▼ | 31.41▲ | 30.69▲ | 29.52▲ |
| MA10 | 30.87▲ | 30.87▲ | 30.69▲ | 30.10▲ | 28.39▲ |
| MA20 | 30.33▲ | 30.36▲ | 30.28▲ | 29.45▲ | 28.90▲ |
| MA50 | 29.55▲ | 29.43▲ | 29.42▲ | 28.13▲ | N/A |
| MA100 | 29.26▲ | 29.08▲ | 28.65▲ | 28.99▲ | N/A |
| MA200 | 28.38▲ | 28.26▲ | 27.87▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.124▲ | 0.120▲ | 0.139▲ | 0.227▲ | 0.169▲ |
| RSI | 73.591▲ | 72.795▲ | 73.321▲ | 69.512▲ | 63.082▲ |
| STOCH | 91.791▲ | 91.848▲ | 94.154▲ | 88.128▲ | 77.603 |
| WILL %R | -11.574▲ | -11.574▲ | -11.574▲ | -10.914▲ | -6.793▲ |
| CCI | 77.488 | 77.482 | 93.124 | 143.002▲ | 180.879▲ |
|
Monday, May 18, 2020 01:05 AM
SOUTH SAN FRANCISCO, Calif., May 18, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety and ...
|
|
Tuesday, April 21, 2020 03:15 AM
Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear Pharmaceuticals, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/09/26 | 31.44 | 31.51 | 31.35 | 31.41 | 10,231 |
| 10/09/26 | 31.00 | 31.84 | 31.00 | 31.84 | 28,869 |
| 09/09/26 | 30.55 | 30.80 | 30.42 | 30.7135 | 14,997 |
| 08/09/26 | 30.05 | 30.09 | 29.825 | 29.9243 | 31,009 |
| 04/09/26 | 29.28 | 29.64 | 29.28 | 29.575 | 9,375 |
| 03/09/26 | 29.72 | 30.11 | 29.63 | 29.7686 | 33,891 |
| 02/09/26 | 29.76 | 30.15 | 29.615 | 29.93 | 22,449 |
| 01/09/26 | 29.435 | 29.955 | 29.435 | 29.92 | 44,565 |
| 31/08/26 | 29.00 | 29.40 | 29.00 | 29.25 | 215,756 |
| 28/08/26 | 28.64 | 29.03 | 28.61 | 28.66 | 44,898 |
|
|
||||
|
|
||||
|
|